Leiden University Scholarly Publications

Your Search

Enabled Filters

  • (-) = Schlumberger, M.

Refine Results

Resource Type

Availability

Creation Date

Faculty

Collection

Author

Show more

Language

Search results

  • RSS Feed
(1 - 4 of 4)
A noninferiority trial of cabozantinib (C) comparing 60mg vs 140mg orally per day to evaluate the efficacy and safety in patients (pts) with progressive, metastatic medullary thyroid cancer (MTC)
Krajewska, J.; Robinson, B.G.; Keam, B.; Capdevila, J.; Klochikhin, A.; Gan, H.; ... ; Schlumberger, M. 2018
A noninferiority trial of cabozantinib (C) comparing 60mg vs 140mg orally per day to evaluate the efficacy and safety in patients (pts) with progressive, metastatic medullary thyroid cancer (MTC)
Other
metadata only
Combination Chemotherapy in Advanced Adrenocortical Carcinoma
Fassnacht, M.; Terzolo, M.; Allolio, B.; Baudin, E.; Haak, H.; Berruti, A.; ... ; FIRM-ACT Study Grp 2012
Combination Chemotherapy in Advanced Adrenocortical Carcinoma
Article / Letter to editor
metadata only
Rationale and design of decision: a double-blind, randomized, placebo-controlled phase III trial evaluating the efficacy and safety of sorafenib in patients with locally advanced or metastatic radioactive iodine (RAI)-refractory, differentiated thyroid ca
Brose, M.S.; Nutting, C.M.; Sherman, S.I.; Shong, Y.K.; Smit, J.W.A.; Reike, G.; ... ; Schlumberger, M. 2011
Rationale and design of decision: a double-blind, randomized, placebo-controlled phase III trial evaluating the efficacy and safety of sorafenib in patients with locally advanced or metastatic radioactive iodine (RAI)-refractory, differentiated thyroid cancer
Article / Letter to editor
metadata only
Plasma Concentrations of o,p ' DDD, o,p ' DDA, and o,p ' DDE as Predictors of Tumor Response to Mitotane in Adrenocortical Carcinoma: Results of a Retrospective ENS@T Multicenter Study
Hermsen, I.G.; Fassnacht, M.; Terzolo, M.; Houterman, S.; Hartigh, J. den; Leboulleux, S.; ... ; Baudin, E. 2011
Plasma Concentrations of o,p ' DDD, o,p ' DDA, and o,p ' DDE as Predictors of Tumor Response to Mitotane in Adrenocortical Carcinoma: Results of a Retrospective ENS@T Multicenter Study
Article / Letter to editor
metadata only